株式会社KORTUC
Palo Alto, US · 1 known investors
KORTUC develops a cancer radiotherapy (code name KRC-01) that uses hydrogen peroxide as a radiosensitizer to treat solid tumors. The company operates in the biopharmaceutical and radiation oncology space.
Founders & leadership
KM
Kazu MatsudaCEO
Board
YO
Yasuhiro OgawaInventor & Medical Advisor
Investors · 1
Frequently asked questions
- What does 株式会社KORTUC do?
- KORTUC develops a cancer radiotherapy (code name KRC-01) that uses hydrogen peroxide as a radiosensitizer to treat solid tumors. The company operates in the biopharmaceutical and radiation oncology space.
- Who are 株式会社KORTUC's investors?
- 株式会社KORTUC's investors include Iyogin Capital.
- Where is 株式会社KORTUC headquartered?
- 株式会社KORTUC is headquartered in Palo Alto, US.